Skip to main content
. 2024 Mar 5;12(5):591. doi: 10.3390/healthcare12050591

Table 3.

Anthropometric and body composition characteristics of participants in the case-control groups.

Control Group MASLD p-Value
Weight (kg) (Mean ± SD) 79.57 ± 11.5 89.98 ± 15.8 0.000
Waist circumference (cm) (Mean ± SD) 100.95 ± 11.37 112.83 ± 12.95 0.000
N (%) N (%)
Body Mass Index (BMI) 30.05 (5.4) 35.04 (6.4) 0.000
BMI categories Normal body weight 8 (13.3) 4 (6.7) 0.000
Overweight 22 (36.7) 4 (6.7)
Obesity 30 (50.0) 52 (86.7)
Waist Circumference Categories Low risk 9 (15.0) 1 (1.7) 0.000
Elevated risk 24 (40.0) 10 (16.7)
High Risk 27 (45.0) 49 (81.7)
Fat Mass Categories Low 1 (1.7) 0 (0.0) 0.070
Normal 4 (6.7) 4 (6.7)
High 8 (13.3) 1 (1.7)
Very High 47 (78.3) 55 (91.7)
Muscle Mass Category Low 38 (63.3) 47 (78.3) 0.12
Normal 11 (18.3) 5 (8.3)
High 5 (8.3) 2 (3.3)
Very high 6 (10.0) 6 (10.0)
Visceral Fat Categories Normal 33 (55.0) 15 (25.0) 0.008
High 25 (41.7) 40 (66.7)
Very High 2 (3.3) 4 (8.3)
Visceral obesity No 12 (20.0) 3 (5.0) 0.013
Yes 48 (80.0) 57 (95.0)
Sarcopenia No 8 (13.0) 6 (10.0) 0.57
Yes 52 (86.7) 54 (90.0)
Sarcopenic-obesity No 16 (26.7) 7 (11.7) 0.037
Yes 44 (73.3) 53 (88.3)